Mild pulmonary fibrosis generally does not affect life expectancy, but the prerequisite is to prevent the progression of pulmonary fibrosis, and at the same time to take reasonable treatment measures and standardize the use of medication, otherwise the rapid progression or further development of pulmonary fibrosis will significantly affect the patient’s life expectancy.
Pulmonary fibrosis refers to fibrotic changes in the interstitium of the lungs, which is irreversible, caused by many reasons, may be the previous occurrence of viral pneumonia legacy of pulmonary fibrosis, but also some extrapulmonary diseases, such as acid reflux, rheumatoid immune diseases and medications, etc., this situation should first remove the causes and triggers, targeted treatment.
If it is viral pneumonia, antiviral treatment is needed; if it is caused by gastric acid reflux, drugs that inhibit gastric acid secretion, such as omeprazole, are needed; if it is secondary to rheumatic immune diseases, treatment of the primary disease is needed, and some anti-pulmonary fibrosis drugs, such as nidazole, can be used at the same time.
Usually should pay attention to maintain good habits, avoid smoking and second-hand smoke, active physical exercise, prevention of upper respiratory tract infections, if you feel unwell to consult a doctor in a timely manner.